Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jun;21(6):947-50.
doi: 10.1128/jcm.21.6.947-950.1985.

Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants

Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants

D C Mills et al. J Clin Microbiol. 1985 Jun.

Abstract

Isolation of lipase-positive Clostridium botulinum from fecal specimens establishes the diagnosis of infant botulism, contributes to the diagnosis of food-borne botulism, and is most easily accomplished by use of selective media. Modification of an available selective medium, C. botulinum inhibitory medium (CBI), enabled more rapid isolation of C. botulinum. The modified medium (botulinum selective medium [BSM] contained (per liter) 25 g of dehydrated heart infusion broth, 20 g of agar, 30 ml of egg yolk suspension, 250 mg of cycloserine, 76 mg of sulfamethoxazole, 4 mg of trimethoprim, and 100 IU of thymidine phosphorylase at pH 7.4. The two media were compared by using 15 fresh fecal specimens from infant botulism patients (10 type A and 5 type B) and a C. botulinum isolate that had been obtained from an infant botulism patient and that was mixed into a fresh stool specimen from a healthy human infant. In comparison to CBI, BSM always provided better suppression of the nonbotulinum fecal flora and earlier emergence of lipase-positive colonies. Diagnosis of infant botulism was accomplished sooner with BSM than with CBI because isolation of lipase-positive C. botulinum was easier.

PubMed Disclaimer

References

    1. Appl Microbiol. 1967 Mar;15(2):426-30 - PubMed
    1. Med J Aust. 1983 Jan 8;1(1):4-5 - PubMed
    1. Antimicrob Agents Chemother. 1975 Jan;7(1):91-8 - PubMed
    1. N Engl J Med. 1976 Sep 30;295(14):770-2 - PubMed
    1. Lancet. 1976 Oct 30;2(7992):934-6 - PubMed

Publication types